The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients

NCT04410341 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Institutional and funding constrains

Conditions

Major Depressive Disorder

Interventions

DRUG: Vildagliptin 50 MG
DRUG: Escitalopram 20 mg

Sponsor

Sadat City University